Welcome to our dedicated page for Bank7 SEC filings (Ticker: BSVN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Looking for the numbers behind Bank7’s rising loan book or confirmation of the latest insider purchase? Most investors begin with Bank7 insider trading Form 4 transactions or the detailed credit tables in the 10-K. This page puts every Bank7 Corp (BSVN) filing in one place and answers the natural questions you already ask, from “Where is the Bank7 quarterly earnings report 10-Q filing?” to “How do I track Bank7 executive stock transactions Form 4 before market moves?”
Stock Titan’s AI reads each document the moment it lands on EDGAR, then delivers plain-English highlights so you can start understanding Bank7 SEC documents with AI instead of combing through footnotes. Whether you need the allowance for loan losses tucked deep in the Bank7 annual report 10-K simplified, an alert on deposit cost trends in the next 10-Q, or a heads-up on expansion news in a new 8-K, our platform surfaces the right paragraph instantly.
- Real-time feed of every submission, including Bank7 Form 4 insider transactions real-time and 8-K event notices.
- Concise AI summaries that turn a 300-page filing into a five-minute brief—ideal for quick Bank7 earnings report filing analysis.
- Direct links to key sections: capital ratios, energy loan exposure, and the Bank7 proxy statement executive compensation tables.
Need context on a sudden branch opening or credit provision shift? The “Bank7 8-K material events explained” panel highlights what changed and why it matters. From dividend declarations to community-bank risk metrics, our coverage ensures Bank7 SEC filings explained simply are only a click away, letting you act on insights instead of searching for them.
Bank7 Corp. (BSVN) Form 4: Kelly J. Harris, Executive Vice President and Chief Financial Officer, reported open-market sales of the issuer's common stock on 09/02/2025 and 09/03/2025. On 09/02/2025 he sold 1,688 shares at a weighted-average price of $49.2795, reducing his beneficial ownership to 20,895 shares. On 09/03/2025 he sold 3,312 shares at a weighted-average price of $48.383, reducing his beneficial ownership to 17,583 shares. Holdings include multiple restricted stock unit grants with staggered vesting through 2028.
Bank7 Corp. (BSVN) Form 144 filing: An individual notified intent to sell 5,000 shares of Bank7 common stock on 09/02/2025 through Stifel Nicolaus. The reported aggregate market value of the proposed sale is $246,398.00. The filer states the shares were acquired as Restricted Stock Units on 09/20/2022, totaling 6,523 units, with cash used for payment on the acquisition date. The issuer has 9,450,979 shares outstanding per the form. No sales by the filer in the prior three months were reported.
Travis Thomas L, President & CEO and director of Bank7 Corp. (BSVN), reported a sale of 13,084 shares of common stock on 08/26/2025 at a weighted-average price of $49.3566. After the sale, he beneficially owns 286,293 shares. The filing notes that the sale occurred in multiple transactions with prices ranging from $49.16 to $49.55. The reported holdings include several restricted stock unit (RSU) balances that vest on specified future dates, with detailed vesting schedules disclosed for multiple grants. No derivative transactions were reported.
Form 144 notice for Bank7 Corp. (BSVN) records a proposed sale of 13,084 shares of common stock through Stifel Nicolaus & Company Inc. with an aggregate market value of $645,782.00. The filing lists 9,450,979 shares outstanding for the issuer and an approximate sale date of 08/26/2025 on the Nasdaq. The shares were acquired as Restricted Stock Units from the issuer on 09/21/2021, with 65,500 units originally acquired and payment noted as cash on the acquisition date. The filer reports no securities sold in the past three months and includes the standard attestation that no undisclosed material adverse information is known.
FAQ
What is the current stock price of Bank7 (BSVN)?
What is the market cap of Bank7 (BSVN)?
